Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2013

Stockholders' Equity Note [Abstract]

Summary of activity under stock incentive plans

A summary of the activity under the Endo 2000, 2004, 2007, and 2010 Stock Incentive Plans and the Endo Health Solutions Inc. Assumed Stock Incentive Plan for the three months ended March 31, 2013 is presented below:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding as of January 1, 2013	8,824,705		$	27.92
Granted	583,045		$	30.70
Exercised	(552,072	)	$	23.21
Forfeited	(398,373	)	$	32.85
Expired	(19,770	)	$	29.83
Outstanding as of March 31, 2013	8,437,535		$	28.24	5.72	$	33,933,099
Vested and expected to vest as of March 31, 2013	7,990,187		$	28.01	5.60	$	33,587,010
Exercisable as of March 31, 2013	4,909,164		$	25.78	4.47	$	28,552,541

Stock option assumption

The weighted average grant date fair value of the stock options granted in the three months ended March 31, 2013 and 2012 was $9.33 and $10.57 per option, respectively, determined using the following assumptions:

	March 31, 2013		March 31, 2012
Average expected term (years)	5.0		5.0
Risk-free interest rate	0.8	%	0.9	%
Dividend yield	—		—
Expected volatility	33	%	33	%

Summary of restricted stock units activity

A summary of our restricted stock units for the three months ended March 31, 2013 is presented below:

	Number of Shares		Aggregate Intrinsic Value
Outstanding as of January 1, 2013	2,423,612
Granted	1,306,003
Forfeited	(150,843	)
Vested	(676,149	)
Outstanding as of March 31, 2013	2,902,623		$	88,740,451
Vested and expected to vest as of March 31, 2013	2,473,162		$	72,812,016

Summary of restricted stock activity

A summary of our restricted stock awards for the three months ended March 31, 2013 is presented below:

	Number of Shares		Weighted Average Fair Value Per Share		Aggregate Intrinsic Value
Non-vested as of January 1, 2013	81,651		$	31.45
Granted	—		$	—
Forfeited	(4,294	)	$	31.52
Vested	(17,424	)	$	31.77	$	535,962
Non-vested as of March 31, 2013	59,933		$	31.35

Schedule of changes in stockholders' equity

The following table displays a reconciliation of our beginning and ending balances in stockholders’ equity for the three months ended March 31, 2013 (dollars in thousands):

	Attributable to:
	Endo Health Solutions Inc.			Noncontrolling interests			Total Stockholders’ Equity
Stockholders’ equity at January 1, 2013	$	1,072,856		$	60,350		$	1,133,206
Net income	15,349			11,254			26,603
Other comprehensive loss	(2,364		)	—			(2,364		)
Compensation related to stock-based awards	15,331			—			15,331
Exercise of options	12,826			—			12,826
Common stock issued from treasury, net of common stock purchased	1,557			—			1,557
Distributions to noncontrolling interests	—			(12,832		)	(12,832		)
Buy-out of noncontrolling interests, net of contributions	—			(1,406		)	(1,406		)
Other	(1,184		)	—			(1,184		)
Stockholders’ equity at March 31, 2013	$	1,114,371		$	57,366		$	1,171,737

The following table displays a reconciliation of our beginning and ending balances in stockholders’ equity for the three months ended March 31, 2012 (dollars in thousands):

	Attributable to:
	Endo Health Solutions Inc.			Noncontrolling interests			Total Stockholders’ Equity
Stockholders’ equity at January 1, 2012	$	1,977,690		$	61,901		$	2,039,591
Net (loss) income	(87,345		)	12,820			(74,525		)
Other comprehensive income	2,242			—			2,242
Compensation related to stock-based awards	14,518			—			14,518
Exercise of options	12,232			—			12,232
Common stock purchased, net of common stock issued from treasury	(31,588		)	—			(31,588		)
Distributions to noncontrolling interests	—			(13,120		)	(13,120		)
Buy-out of noncontrolling interests, net of contributions	—			(849		)	(849		)
Other	1,384			—			1,384
Stockholders’ equity at March 31, 2012	$	1,889,133		$	60,752		$	1,949,885